CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size

Anna Lisa Ludwig, Glenda M. Espinal, Dalyir I. Pretto, Amanda L. Jamal, Gloria Arque, Flora Tassone, Robert F Berman, Paul J Hagerman

Research output: Contribution to journalArticle

39 Citations (Scopus)

Abstract

Large expansions of a CGG-repeat element (>200 repeats; full mutation) in the fragile X mental retardation 1 (FMR1) gene cause fragile X syndrome (FXS), the leading single-gene form of intellectual disability and of autism spectrum disorder. Smaller expansions (55-200CGGrepeats; premutation) result in theneurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS). Whereas FXS is caused by gene silencing and insufficient FMR1 protein (FMRP), FXTAS is thought to be caused by 'toxicity' of expanded-CGG-repeat mRNA. However, as FMRP expression levels decrease with increasing CGG-repeat length, lowered protein may contribute to premutation-associated clinical involvement. To address this issue, we measured brain Fmr1 mRNA and FMRP levels as a function of CGG-repeat length in a congenic (CGG-repeat knock-in) mouse model using 57 wild-type and 97 expanded-CGG-repeat mice carrying up tõ250 CGG repeats. While Fmr1message levels increasedwith repeat length,FMRPlevels trended downward over thesamerange, subject to significant inter-subject variation.Human comparisons of protein levels in the frontal cortex of 7 normal and 17 FXTAS individuals revealed that the mildFMRPdecrease in mice mirrored the more limited data forFMRP expression in thehumansamples. In addition,FMRPexpression levels varied in a subset ofmiceacross the cerebellum, frontal cortex,andhippocampus,aswell asat different ages.Theseresults provide a foundation for understandingboth the CGG-repeat-dependence of FMRP expression and for interpreting clinical phenotypes in premutation carriers in terms of the balance between elevated mRNA and lowered FMRP expression levels.

Original languageEnglish (US)
Pages (from-to)3228-3238
Number of pages11
JournalHuman Molecular Genetics
Volume23
Issue number12
DOIs
StatePublished - 2014

Fingerprint

Fragile X Syndrome
Proteins
Frontal Lobe
Intellectual Disability
Messenger RNA
Fragile X Mental Retardation Protein
Gene Silencing
Cerebellum
Genes
Phenotype
Mutation
Brain
Fragile X Tremor Ataxia Syndrome
Autism Spectrum Disorder

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)
  • Molecular Biology
  • Medicine(all)

Cite this

CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. / Ludwig, Anna Lisa; Espinal, Glenda M.; Pretto, Dalyir I.; Jamal, Amanda L.; Arque, Gloria; Tassone, Flora; Berman, Robert F; Hagerman, Paul J.

In: Human Molecular Genetics, Vol. 23, No. 12, 2014, p. 3228-3238.

Research output: Contribution to journalArticle

Ludwig, Anna Lisa ; Espinal, Glenda M. ; Pretto, Dalyir I. ; Jamal, Amanda L. ; Arque, Gloria ; Tassone, Flora ; Berman, Robert F ; Hagerman, Paul J. / CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size. In: Human Molecular Genetics. 2014 ; Vol. 23, No. 12. pp. 3228-3238.
@article{312e32eccf92474e8092bcd289b02077,
title = "CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size",
abstract = "Large expansions of a CGG-repeat element (>200 repeats; full mutation) in the fragile X mental retardation 1 (FMR1) gene cause fragile X syndrome (FXS), the leading single-gene form of intellectual disability and of autism spectrum disorder. Smaller expansions (55-200CGGrepeats; premutation) result in theneurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS). Whereas FXS is caused by gene silencing and insufficient FMR1 protein (FMRP), FXTAS is thought to be caused by 'toxicity' of expanded-CGG-repeat mRNA. However, as FMRP expression levels decrease with increasing CGG-repeat length, lowered protein may contribute to premutation-associated clinical involvement. To address this issue, we measured brain Fmr1 mRNA and FMRP levels as a function of CGG-repeat length in a congenic (CGG-repeat knock-in) mouse model using 57 wild-type and 97 expanded-CGG-repeat mice carrying up t{\~o}250 CGG repeats. While Fmr1message levels increasedwith repeat length,FMRPlevels trended downward over thesamerange, subject to significant inter-subject variation.Human comparisons of protein levels in the frontal cortex of 7 normal and 17 FXTAS individuals revealed that the mildFMRPdecrease in mice mirrored the more limited data forFMRP expression in thehumansamples. In addition,FMRPexpression levels varied in a subset ofmiceacross the cerebellum, frontal cortex,andhippocampus,aswell asat different ages.Theseresults provide a foundation for understandingboth the CGG-repeat-dependence of FMRP expression and for interpreting clinical phenotypes in premutation carriers in terms of the balance between elevated mRNA and lowered FMRP expression levels.",
author = "Ludwig, {Anna Lisa} and Espinal, {Glenda M.} and Pretto, {Dalyir I.} and Jamal, {Amanda L.} and Gloria Arque and Flora Tassone and Berman, {Robert F} and Hagerman, {Paul J}",
year = "2014",
doi = "10.1093/hmg/ddu032",
language = "English (US)",
volume = "23",
pages = "3228--3238",
journal = "Human Molecular Genetics",
issn = "0964-6906",
publisher = "Oxford University Press",
number = "12",

}

TY - JOUR

T1 - CNS expression of murine fragile X protein (FMRP) as a function of CGG-repeat size

AU - Ludwig, Anna Lisa

AU - Espinal, Glenda M.

AU - Pretto, Dalyir I.

AU - Jamal, Amanda L.

AU - Arque, Gloria

AU - Tassone, Flora

AU - Berman, Robert F

AU - Hagerman, Paul J

PY - 2014

Y1 - 2014

N2 - Large expansions of a CGG-repeat element (>200 repeats; full mutation) in the fragile X mental retardation 1 (FMR1) gene cause fragile X syndrome (FXS), the leading single-gene form of intellectual disability and of autism spectrum disorder. Smaller expansions (55-200CGGrepeats; premutation) result in theneurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS). Whereas FXS is caused by gene silencing and insufficient FMR1 protein (FMRP), FXTAS is thought to be caused by 'toxicity' of expanded-CGG-repeat mRNA. However, as FMRP expression levels decrease with increasing CGG-repeat length, lowered protein may contribute to premutation-associated clinical involvement. To address this issue, we measured brain Fmr1 mRNA and FMRP levels as a function of CGG-repeat length in a congenic (CGG-repeat knock-in) mouse model using 57 wild-type and 97 expanded-CGG-repeat mice carrying up tõ250 CGG repeats. While Fmr1message levels increasedwith repeat length,FMRPlevels trended downward over thesamerange, subject to significant inter-subject variation.Human comparisons of protein levels in the frontal cortex of 7 normal and 17 FXTAS individuals revealed that the mildFMRPdecrease in mice mirrored the more limited data forFMRP expression in thehumansamples. In addition,FMRPexpression levels varied in a subset ofmiceacross the cerebellum, frontal cortex,andhippocampus,aswell asat different ages.Theseresults provide a foundation for understandingboth the CGG-repeat-dependence of FMRP expression and for interpreting clinical phenotypes in premutation carriers in terms of the balance between elevated mRNA and lowered FMRP expression levels.

AB - Large expansions of a CGG-repeat element (>200 repeats; full mutation) in the fragile X mental retardation 1 (FMR1) gene cause fragile X syndrome (FXS), the leading single-gene form of intellectual disability and of autism spectrum disorder. Smaller expansions (55-200CGGrepeats; premutation) result in theneurodegenerative disorder, fragile X-associated tremor/ataxia syndrome (FXTAS). Whereas FXS is caused by gene silencing and insufficient FMR1 protein (FMRP), FXTAS is thought to be caused by 'toxicity' of expanded-CGG-repeat mRNA. However, as FMRP expression levels decrease with increasing CGG-repeat length, lowered protein may contribute to premutation-associated clinical involvement. To address this issue, we measured brain Fmr1 mRNA and FMRP levels as a function of CGG-repeat length in a congenic (CGG-repeat knock-in) mouse model using 57 wild-type and 97 expanded-CGG-repeat mice carrying up tõ250 CGG repeats. While Fmr1message levels increasedwith repeat length,FMRPlevels trended downward over thesamerange, subject to significant inter-subject variation.Human comparisons of protein levels in the frontal cortex of 7 normal and 17 FXTAS individuals revealed that the mildFMRPdecrease in mice mirrored the more limited data forFMRP expression in thehumansamples. In addition,FMRPexpression levels varied in a subset ofmiceacross the cerebellum, frontal cortex,andhippocampus,aswell asat different ages.Theseresults provide a foundation for understandingboth the CGG-repeat-dependence of FMRP expression and for interpreting clinical phenotypes in premutation carriers in terms of the balance between elevated mRNA and lowered FMRP expression levels.

UR - http://www.scopus.com/inward/record.url?scp=84897370853&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897370853&partnerID=8YFLogxK

U2 - 10.1093/hmg/ddu032

DO - 10.1093/hmg/ddu032

M3 - Article

C2 - 24463622

AN - SCOPUS:84897370853

VL - 23

SP - 3228

EP - 3238

JO - Human Molecular Genetics

JF - Human Molecular Genetics

SN - 0964-6906

IS - 12

ER -